0001214659-21-003609.txt : 20210330
0001214659-21-003609.hdr.sgml : 20210330
20210330165727
ACCESSION NUMBER: 0001214659-21-003609
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210326
FILED AS OF DATE: 20210330
DATE AS OF CHANGE: 20210330
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chang David D
CENTRAL INDEX KEY: 0001611024
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38693
FILM NUMBER: 21787230
MAIL ADDRESS:
STREET 1: C/O ALLOGENE THERAPEUTICS, INC.
STREET 2: 210 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Allogene Therapeutics, Inc.
CENTRAL INDEX KEY: 0001737287
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 823562771
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 210 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 457-2700
MAIL ADDRESS:
STREET 1: 210 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
marketforms-52127.xml
PRIMARY DOCUMENT
X0306
4
2021-03-26
0001737287
Allogene Therapeutics, Inc.
ALLO
0001611024
Chang David D
210 EAST GRAND AVENUE
SOUTH SAN FRANCISCO
CA
94080
true
true
false
false
President and CEO
Common Stock
2021-03-26
4
A
false
80452
0.00
A
2284869
D
Common Stock
1201108
I
See footnote
Common Stock
650266
I
See footnote
Common Stock
650266
I
See footnote
Stock Option (Right to Buy)
33.78
2021-03-26
4
A
false
298836
0.00
A
2031-03-26
Common Stock
298836
298836
D
Securities held in the name of the Chang 2006 Family Trust.
Securities held in the name of the JEC 2019 Trust dated October 1, 2019.
Securities held in the name of the RTC 2019 Trust dated October 1, 2019.
25% of the shares subject to the stock option shall vest on March 13, 2022, and the remaining shares shall vest in 36 equal monthly installments thereafter.
/s/ Veer Bhavnagri, Attorney-in-Fact
2021-03-30